IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases
US11926663B2 · kind B2 · utility
0Cited by
8References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 8, 2021 |
| Grant date | Mar 12, 2024 |
| Priority date | — |
| Expiry date | Apr 16, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/54
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the diseases and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.